Minimizing the inhaled dose of NO with breath-by-breath delivery of spikes of concentrated gas

被引:26
作者
Katayama, Y [1 ]
Higenbottam, TW [1 ]
Cremona, G [1 ]
Akamine, S [1 ]
Demoncheaux, EAG [1 ]
Smith, APL [1 ]
Siddons, TE [1 ]
机构
[1] Univ Sheffield, Sch Med, Sect Resp Med, Div Med Pharmacol & Med Phys, Sheffield S10 2TN, S Yorkshire, England
关键词
hypertension; pulmonary; lung; vasodilation;
D O I
10.1161/01.CIR.98.22.2429
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Pulmonary vasodilatation with a 100 ppm concentration of NO given as a short burst of a few milliliters at the beginning of each breath (NOmin) was compared with conventionally inhaled NO, in which a full breath of 40 ppm of NO was inhaled (NOCD). Methods and Results-NOmin was studied in 16 patients with severe pulmonary hypertension and in 16 isolated porcine lungs with experimentally induced pulmonary hypertension. We compared volumes of 8 to 38 mt of 100 ppm NO in N-2 injected at the beginning of each breath with conventional inhalation of 40 ppm NO in air. NOCD and NOmin were studied in 4 pigs after inhibition of NO synthase with N-G-nitro-L-arginine methyl ester (1 to 2 mg/kg IV) had raised the pulmonary vascular resistance index (PVRI) from 4.4+/-0.8 to 10.0+/-1.6 mm Hg.L-1.min(-1).kg(-1). A similar comparison was made in 7 isolated porcine lungs after the thromboxane analogue U46619 (10 pmol.L-1.min(-1)) increased the mean PVRI from 4.6+/-0.8 to 12.2+/-1.3 mm Hg.L-1.min(-1).kg(-1). Patients' mean PVRI was reduced from 29.2+/-3.7 to 24.0+/-3.1 with NOmin and 24.5+/-3.3 mm Hg.L-1.min(-1).m(-2) (mean+/-SEM) with NOCD. In isolated porcine lungs, there was the same reduction of PVRI for NOmin and NOCD between 12.7% and 34.8%. Conclusions-A small volume of NO inhaled at the beginning of the breath was equally effective as NOCD but reduced the dose of NO per breath by 40-fold, which ranged from 1.2X10(-8) (0.4 mu g) to 1.6X10(-7) mol/L (4.8 mu g) compared with 5.3X10(-7) (16 mu g) to 1.2X10(-6) mol/L (36 mu g) per breath with NOCD.
引用
收藏
页码:2429 / 2432
页数:4
相关论文
共 26 条
[1]   SAFETY OF INHALED NITRIC-OXIDE IN PREMATURE NEONATES [J].
AHLUWALIA, JS ;
KELSALL, AWR ;
RAINE, J ;
RENNIE, JM ;
MAHMOOD, M ;
ODURO, A ;
LATIMER, R ;
PICKETT, J ;
HIGENBOTTAM, TW .
ACTA PAEDIATRICA, 1994, 83 (03) :347-348
[2]   Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease [J].
Barbera, JA ;
Roger, N ;
Roca, J ;
Rovira, I ;
Higenbottam, TW ;
RodriguezRoisin, R .
LANCET, 1996, 347 (8999) :436-440
[3]  
BORLAND CDR, 1989, EUR RESPIR J, V2, P56
[4]   Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension - An ambulatory delivery system and initial clinical tests [J].
Channick, RN ;
Newhart, JW ;
Johnson, FW ;
Williams, PJ ;
Auger, WR ;
Fedullo, PF ;
Moser, KM .
CHEST, 1996, 109 (06) :1545-1549
[5]   Nature and site of action of endogenous nitric oxide in vasculature of isolated pig lungs [J].
Cremona, G ;
Higenbottam, T ;
Takao, M ;
Bower, EA ;
Hall, LW .
JOURNAL OF APPLIED PHYSIOLOGY, 1997, 82 (01) :23-31
[6]   EFFECT OF INHIBITORS OF NITRIC-OXIDE RELEASE AND ACTION ON VASCULAR TONE IN ISOLATED LUNGS OF PIG, SHEEP, DOG AND MAN [J].
CREMONA, G ;
WOOD, AM ;
HALL, LW ;
BOWER, EA ;
HIGENBOTTAM, T .
JOURNAL OF PHYSIOLOGY-LONDON, 1994, 481 (01) :185-195
[7]  
CUSSLER EL, 1994, DIFFUSION MASS TRANS, P105
[8]  
Demoncheaux EAG, 1996, J PHYSIOL-LONDON, V491P, pP101
[9]   SAFETY GUIDELINES FOR USE OF NITRIC-OXIDE [J].
FOUBERT, L ;
FLEMING, B ;
LATIMER, R ;
JONAS, M ;
ODURO, A ;
BORLAND, C ;
HIGENBOTTAM, T .
LANCET, 1992, 339 (8809) :1615-1616
[10]  
HIGENBOTTAM TW, 1993, BRIT HEART J, V70, P366